Evogene (EVGN)
(Delayed Data from NSDQ)
$3.88 USD
+0.33 (9.30%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.75 -0.13 (-3.35%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Evogene Ltd. [EVGN]
Reports for Purchase
Showing records 1 - 20 ( 43 total )
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Big Week for Partnerships to Fund Development Pipelines
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
To Receive $3.5M Collaboration Agreement Payment
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Company: Evogene Ltd.
Industry: Medical - Biomedical and Genetics
Strong Quarter and Good Progress at Lavie Bio and Biomica
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B